3i Group PLC

Report Publication Announcement • Aug 3, 2020

National Storage Mechanism | Additional information

RNS Number : 8279U

LiDCO Group Plc

03 August 2020

LiDCO Group Plc

("LiDCO" or the "Company")

Block Listing Review

LiDCO Group Plc (AIM:LID), the hemodynamic monitoring company, announces the following update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies in respect of its block listing of ordinary shares of 0.5 pence each ("Ordinary Shares").

Name of company	LiDCO Group Plc
Names of the schemes	LiDCO Group Plc Executive Share Option Scheme adopted on 6 June 2001 comprising Part A (Approved.), Part B (Unapproved), and Part C (Incentive Stock Options), the LiDCO Group Plc Enterprise Management Incentive Scheme 2002, the LiDCO Group Plc Unapproved Share Option Plan 2005, the LiDCO Group plc Share Option Plan 2013 formerly called the LiDCO Group Plc Enterprise Management Incentive Scheme 2013, and the LIDCO Group Plc Consultants Share Option Scheme 2003
Period of return	From 1 February 2020 to 31 July 2020
Number and class of securities not issued under the schemes	2,895,396 Ordinary Shares
Number of securities issued under the schemes during the period	Nil
Balance under the schemes of securities not yet issued at the end of the period	2,895,396 Ordinary Shares
Number and class of securities originally admitted and the date of admission	3,200,000 Ordinary Shares on 31 January 2014

For further information, please contact:

LiDCO Group Plc	www.lidco.com
Matthew Sassone (CEO)	Tel: +44 (0)20 7749 1500
Tim Hall (CFO)
N+1 Singer	Tel: +44 (0)20 7496 3172
Aubrey Powell / George Tzimas (Corporate Finance)
Tom Salveson (Corporate Broking)
Walbrook PR Ltd	Tel: 020 7933 8780 or lidco@walbrookpr.com
Paul McManus	Mob: 07980 541 893
Lianne Cawthorne	Mob: 07584 391 303

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRBUGDRUXXDGGB